Diket's Professional Drugs, Inc. (Crawford's Professional Drugs, Inc.), Laurel, MS
Is Diket's Professional Drugs, Inc. (Crawford's Professional Drugs, Inc.) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Diket's Professional Drugs, Inc. (Crawford's Professional Drugs, Inc.) hold a Mississippi pharmacy license?
State board of pharmacy records for Mississippi are not checked: the Board of Pharmacy sends its license roster only by email, after the requester agrees to terms that limit how the data may be used, and its license verification is an interactive search.
Has Diket's Professional Drugs, Inc. (Crawford's Professional Drugs, Inc.) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Jun 27, 2019) and 1 FMD-145 letter (Jun 27, 2019) for Diket's Professional Drugs, Inc. (Crawford's Professional Drugs, Inc.). State board of pharmacy records for Mississippi are not checked: the Board of Pharmacy sends its license roster only by email, after the requester agrees to terms that limit how the data may be used, and its license verification is an interactive search. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Crawford's Professional Drugs, Inc.; Diket's Professional Drugs, Inc.
- Location
- Laurel, MS
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 0
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Jun 27, 2019
- FDA Data Dashboard inspections
- 1 inspection: 1 VAI; 1 published Form 483
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Crawford's Professional Drugs, Inc., (dba Diket's Professional Drugs, Inc.), a 503A facility, with 2 dated actions.
| Document | |||
|---|---|---|---|
| Jun 27, 2019 | State referral letter | Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019 | FDA copy (archived) |
| Jun 27, 2019 | FMD-145 letter | FMD-145 Letter Issued 06/27/2019 | FDA copy (archived) |
An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Crawford's Professional Drugs, Inc., Laurel, MS (FEI number 3014539091), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Nov 29, 2018 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3014539091 | 1072963 |
Form 483s FDA has published for this site
- Nov 29, 2018: Form 483 to Crawford's Professional Drugs, Inc., published Apr 30, 2019. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA links 1 Form 483 PDF for Diket's Professional Drugs, Inc. (Crawford's Professional Drugs, Inc.), but no observation text is shown, for the reasons below.
Linked 483s whose text is not shown
- Nov 29, 2018: FDA document 122501: the PDF is a scanned image with no readable text.
State board of pharmacy records
State board of pharmacy records for Mississippi are not checked: the Board of Pharmacy sends its license roster only by email, after the requester agrees to terms that limit how the data may be used, and its license verification is an interactive search.
This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
Records last pulled Nov 15, 2026. Every entry links to the original public record.